MI4 is dedicated to expanding access to molecular imaging and theranostics by helping organizations implement practical, sustainable, and clinically meaningful programs. We bridge scientific innovation with operational, regulatory, and financial realities—designing workflows, radiopharmaceutical strategies, and implementation models that make advanced diagnostics and targeted therapies accessible across diverse healthcare environments. Through this work, MI4 advances a more inclusive, scalable, and impactful future for precision medicine.